Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-12-12 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
南微医学科技股份有限公司第三届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company 南微医学科技股份有限公司. It details the outcomes of various supervisory board votes on matters such as stock incentive plans, related party transactions, project delays, cash management, and hedging activities. The document does not contain financial statements or detailed financial analysis but rather reports on board decisions and approvals. It is not an annual or interim report, earnings release, or audit report. It is also not a regulatory filing or announcement of voting results from a shareholder meeting. The content fits best under Board/Management Information (MANG) as it relates to internal governance decisions and supervisory board resolutions. The document length is under 5,000 characters and is a formal announcement of board resolutions, not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2022-12-12 Chinese
南京证券股份有限公司关于南微医学2023年度日常关联交易额度预计事项的核查意见
Regulatory Filings
2022-12-12 Chinese
南微医学科技股份有限公司监事会关于2020年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's verification opinion on the vesting list of a 2020 restricted stock incentive plan for a company. It discusses compliance with laws and regulations, the qualification of incentive recipients, and approval of stock vesting. The content is related to stock incentive plan details and supervisory board opinions rather than financial results, management changes, or voting results. It is not an announcement of a report publication but a formal opinion document. This fits best under Regulatory Filings (RNS) as it is a compliance and supervisory opinion document that does not fit other specific categories like Remuneration Information or Share Issue announcements.
2022-12-12 Chinese
南微医学科技股份有限公司关于调整2020年限制性股票激励计划授予数量及价格的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 南微医学科技股份有限公司 regarding adjustments to the 2020 restricted stock incentive plan, specifically about the grant quantity and price. It details board and supervisory meetings, approvals, legal opinions, and the rationale for adjustments due to capital reserve transfers and dividends. The document is a formal announcement of changes to an existing stock incentive plan, not a full financial report, earnings release, or management discussion. It does not contain financial statements or comprehensive financial data but focuses on corporate governance and stock incentive plan adjustments. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about stock incentive plan adjustments and related approvals, without being a full report or a direct capital/financing update like a new financing round or share issuance announcement.
2022-12-12 Chinese
南微医学科技股份有限公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 南微医学科技股份有限公司 (Micro-Tech (Nanjing) Co., Ltd.). It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no indication that this is an annual report, financial statement, earnings release, or any other type of financial or regulatory filing. Instead, it is a governance document that sets out the internal rules and structure of the company. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance provisions, confirming it is not a mere announcement or summary.
2022-12-12 Chinese
南微医学科技股份有限公司持股5%以上股东减持达到1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a shareholder (Huakang Limited) reducing its shareholding by more than 1%, detailing the number of shares sold, dates, and the impact on ownership percentages. It explicitly mentions it is a "持股5%以上股东减持达到1%的提示性公告" which translates to "Announcement of a 1% reduction in shareholding by a shareholder holding more than 5%". This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not a full financial report, earnings release, or management report, nor is it an announcement of a meeting or voting results. It is a regulatory announcement about shareholding changes by a major shareholder.
2022-12-06 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.